Swiss neuroscience and digital-therapeutics company for brain health and recovery.
| Date | Round | Amount |
|---|---|---|
| Mar 2022 | Funding round Lausanne neurotech unicorn MindMaze raised 105M dollars led by Concord Health Partners, with AlbaCore Capital and Hambro Perks. | $92.4M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.